Cardiac Protection in HER2-Targeted Treatment: How Should We Measure New Strategies?

JAMA Oncol. 2016 Aug 1;2(8):1037-9. doi: 10.1001/jamaoncol.2016.0283.
No abstract available

Publication types

  • Comment

MeSH terms

  • Breast Neoplasms*
  • Humans
  • Receptor, ErbB-2*

Substances

  • Receptor, ErbB-2